Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (16.663)

1

Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung : A case report

enthalten in: Human vaccines & immunotherapeutics | 2024

von Huang, X. | Zhu, L. | Pan, W. | +1

2

Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation

enthalten in: Allergy | 2024

von Zheng, Y. | Chen, X. | Wang, Z. | +5

3

Exploratory analysis of the economically justifiable price of nirsevimab for healthy late-preterm and term infants in Colombia

enthalten in: Pediatric pulmonology | 2024

von Buendía, J. | Acuña-Cordero, R. | Rodriguez-Martinez, C.

4

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy : The MITO 44 study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Tuninetti, V. | Virano, E. | Salutari, V. | +21

5

Comprehensive multi-omics analysis of resectable locally advanced gastric cancer : Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial

enthalten in: Clinical and translational medicine | 2024

von Zhao, Y. | Li, D. | Zhuang, J. | +23

6

Real-world effectiveness of ustekinumab and vedolizumab in TNF-exposed pediatric patients with ulcerative colitis

enthalten in: Journal of pediatric gastroenterology and nutrition | 2024

von Patel, P. | Zhang, A. | Bhasuran, B. | +7

7

A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors : A children's oncology group consortium report (ADVL1614)

enthalten in: Pediatric blood & cancer | 2024

von Greengard, E. | Williams, R. | Moriarity, B. | +10

8

Efficacy and safety analysis of Dupilumab for atopic dermatitis of all ages in Chinese population : Real-world data from a single center

enthalten in: Allergy | 2024

von Yang, Z. | Wen, W. | Shi, R. | +6

9

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2024

von Machiels, J. | Tao, Y. | Licitra, L. | +125

10

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC : exploratory analysis from KEYNOTE-522

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Pusztai, L. | Denkert, C. | O'Shaughnessy, J. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1667]